Dr. Agarwal's Health Care (AGARWALEYE) Stock Overview
Dr. Agarwal’s Health Care Limited operates eye hospitals in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for AGARWALEYE from our risk checks.
AGARWALEYE Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Dr. Agarwal's Health Care Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹403.30 |
| 52 Week High | ₹464.00 |
| 52 Week Low | ₹327.00 |
| Beta | 0 |
| 1 Month Change | 3.00% |
| 3 Month Change | -9.35% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| AGARWALEYE | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 7.5% | -1.2% | -1.8% |
| 1Y | n/a | 22.4% | -1.7% |
Return vs Industry: Insufficient data to determine how AGARWALEYE performed against the Indian Healthcare industry.
Return vs Market: Insufficient data to determine how AGARWALEYE performed against the Indian Market.
Price Volatility
| AGARWALEYE volatility | |
|---|---|
| AGARWALEYE Average Weekly Movement | 4.9% |
| Healthcare Industry Average Movement | 5.4% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: AGARWALEYE has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: Insufficient data to determine AGARWALEYE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 4,858 | Adil Agarwal | www.dragarwals.co.in |
Dr. Agarwal’s Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the treatment of glaucoma and pterygium; doctor consultation services; and diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment services.
Dr. Agarwal's Health Care Limited Fundamentals Summary
| AGARWALEYE fundamental statistics | |
|---|---|
| Market cap | ₹127.51b |
| Earnings (TTM) | ₹834.60m |
| Revenue (TTM) | ₹17.11b |
Is AGARWALEYE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AGARWALEYE income statement (TTM) | |
|---|---|
| Revenue | ₹17.11b |
| Cost of Revenue | ₹9.62b |
| Gross Profit | ₹7.49b |
| Other Expenses | ₹6.65b |
| Earnings | ₹834.60m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.64 |
| Gross Margin | 43.76% |
| Net Profit Margin | 4.88% |
| Debt/Equity Ratio | 12.8% |
How did AGARWALEYE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/20 20:08 |
| End of Day Share Price | 2025/06/20 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dr. Agarwal's Health Care Limited is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Alok Dalal | Jefferies LLC |
| Alankar Garude | Kotak Securities (Institutional Equities) |
| Binay Singh | Morgan Stanley |